Finansal

Tartışmalar Teknikler Tahmin Mevsimlik

Ortak hissedarlara sunulan seyreltilmiş net gelir'in HUALAN BIOLOGICAL

Yıllık veri

2019

2020

2021

2022

2023

TTM

‪0,00‬

‪‪250,00 M‬‬

‪‪500,00 M‬‬

‪‪750,00 M‬‬

‪‪1,00 B‬‬

Dönem

Değer

Değişim

Değişim %

TTM

‪‪497,61 M‬‬

‪‪−362,36 M‬‬

‪−42,14‬%

2023

‪‪859,97 M‬‬

+‪‪340,33 M‬‬

+‪65,49‬%

2022

‪‪519,63 M‬‬

‪‪−101,34 M‬‬

‪−16,32‬%

2021

‪‪620,97 M‬‬

‪‪−303,94 M‬‬

‪−32,86‬%

2020

‪‪924,91 M‬‬

+‪‪549,61 M‬‬

+‪146,45‬%

2019

‪‪375,30 M‬‬

+‪‪105,15 M‬‬

+‪38,92‬%

3 ay veri

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−200,00 M‬‬

‪0,00‬

‪‪200,00 M‬‬

‪‪400,00 M‬‬

‪‪600,00 M‬‬

Dönem

Değer

Değişim

Değişim %

Q3 '24

‪‪242,09 M‬‬

+‪‪255,40 M‬‬

—

Q2 '24

‪‪−13,32 M‬‬

‪‪−51,90 M‬‬

‪−134,50‬%

Q1 '24

‪‪38,59 M‬‬

‪‪−191,66 M‬‬

‪−83,24‬%

Q4 '23

‪‪230,25 M‬‬

‪‪−291,24 M‬‬

‪−55,85‬%

Q3 '23

‪‪521,50 M‬‬

+‪‪507,24 M‬‬

+‪‪3,56 K‬‬%

Q2 '23

‪‪14,25 M‬‬

‪‪−79,72 M‬‬

‪−84,83‬%

Q1 '23

‪‪93,97 M‬‬

+‪‪79,04 M‬‬

+‪529,53‬%

Q4 '22

‪‪14,93 M‬‬

‪‪−191,59 M‬‬

‪−92,77‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20